G. Shankar

522 total citations
24 papers, 380 citations indexed

About

G. Shankar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Civil and Structural Engineering. According to data from OpenAlex, G. Shankar has authored 24 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Civil and Structural Engineering. Recurrent topics in G. Shankar's work include Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). G. Shankar is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). G. Shankar collaborates with scholars based in United States, India and Spain. G. Shankar's co-authors include Md Azree Othuman Mydin, P. Štern, P. Lakatos, Stephen J. Foster, Mohd Yazid Mohd Yunos, William T. Mason, H. Kalervo Väänänen, Michael J. Barnes, Donna L. Mendrick and Päivi T. Lakkakorpi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Endocrinology.

In The Last Decade

G. Shankar

22 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Shankar United States 9 140 136 79 78 63 24 380
Mohammad Sotoudeh United States 6 163 1.2× 16 0.1× 30 0.4× 34 0.4× 23 0.4× 10 395
Guanzhi Liu China 10 116 0.8× 25 0.2× 32 0.4× 12 0.2× 32 0.5× 36 300
Zhengxiang Yang China 11 296 2.1× 69 0.5× 30 0.4× 30 0.4× 23 0.4× 13 469
Guangwen Wang China 10 555 4.0× 50 0.4× 18 0.2× 11 0.1× 37 0.6× 34 722
Shaolong Zhou China 15 202 1.4× 95 0.7× 13 0.2× 47 0.6× 7 0.1× 37 566
Q Mai China 4 130 0.9× 6 0.0× 8 0.1× 34 0.4× 5 0.1× 5 343
Jae-Il Choi South Korea 8 106 0.8× 40 0.3× 13 0.2× 7 0.1× 5 0.1× 9 332
Shiwang Li China 15 321 2.3× 102 0.8× 24 0.3× 96 1.2× 2 0.0× 40 785
Yan‐Bin Ma China 13 274 2.0× 73 0.5× 31 0.4× 42 0.5× 1 0.0× 34 469
Hongbo Lu China 6 161 1.1× 246 1.8× 5 0.1× 29 0.4× 1 0.0× 16 439

Countries citing papers authored by G. Shankar

Since Specialization
Citations

This map shows the geographic impact of G. Shankar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Shankar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Shankar more than expected).

Fields of papers citing papers by G. Shankar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Shankar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Shankar. The network helps show where G. Shankar may publish in the future.

Co-authorship network of co-authors of G. Shankar

This figure shows the co-authorship network connecting the top 25 collaborators of G. Shankar. A scholar is included among the top collaborators of G. Shankar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Shankar. G. Shankar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Desai, Padmashree, et al.. (2023). American Sign Language Fingerspelling Recognition using Attention Model. 1–6. 1 indexed citations
3.
Shankar, G., et al.. (2023). Exploratory Data Analysis on Blueberry yield through Bayes and Function Models. International Journal on Recent and Innovation Trends in Computing and Communication. 11(11s). 634–641.
4.
Shankar, G., et al.. (2022). A New Improved Binary Convolutional Model for Classification of Images. Scalable Computing Practice and Experience. 23(4). 263–274. 1 indexed citations
5.
Reck, Martin, Tony Mok, Mark A. Socinski, et al.. (2020). 1293P IMpower150: Updated efficacy analysis in patients with EGFR mutations. Annals of Oncology. 31. S837–S838. 12 indexed citations
6.
West, Howard, Federico Cappuzzo, Martin Reck, et al.. (2020). 1265P IMpower150: A post hoc analysis of efficacy outcomes in patients with KRAS, STK11 and KEAP1 mutations. Annals of Oncology. 31. S817–S818. 14 indexed citations
7.
Reck, Martin, Robert M. Jotte, Tony Mok, et al.. (2019). IMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations. Annals of Oncology. 30. ii48–ii49. 7 indexed citations
8.
Rothenstein, J., Alexander I. Spira, Vamsidhar Velcheti, et al.. (2018). P1.01-83 IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab. Journal of Thoracic Oncology. 13(10). S495–S495. 3 indexed citations
9.
10.
Kowanetz, Marcin, Wei Zou, David S. Shames, et al.. (2016). Tumor mutation load assessed by FoundationOne (FM1) is associated with improved efficacy of atezolizumab (atezo) in patients with advanced NSCLC. Annals of Oncology. 27. vi23–vi23. 34 indexed citations
11.
Mydin, Md Azree Othuman, et al.. (2016). STRUCTURAL BEHAVIOUR OF COIR FIBRE-REINFORCED FOAMED CONCRETE WALL PANEL SYSTEM. Jurnal Teknologi. 78(5). 12 indexed citations
12.
Herbst, Roy S., Filippo de Marinis, Jacek Jassem, et al.. (2015). 355TiP Phase III clinical trials of atezolizumab compared with standard chemotherapy in PD-L1–selected chemotherapy-naïve patients with advanced NSCLC. Annals of Oncology. 26. ix103–ix103. 3 indexed citations
13.
Shankar, G., Md Azree Othuman Mydin, Mohd Yazid Mohd Yunos, & Mohd Nasrun Mohd Nawi. (2015). Thermal Properties of Foamed Concrete with Various Densities and Additives at Ambient Temperature. Applied Mechanics and Materials. 747. 230–233. 40 indexed citations
14.
15.
Lolkema, Martijn P., Siew Hong Leong, G. Shankar, et al.. (2012). 365 A Phase 1b Open-label, Dose-escalation Study of the Safety and Pharmacology of GDC-0941 in Combination with Erlotinib in Patients with Advanced Solid Tumors. European Journal of Cancer. 48. 111–112. 2 indexed citations
16.
17.
Besse, Benjamin, Jean‐Charles Soria, Carlos Gomez‐Roca, et al.. (2011). A phase Ib study to evaluate the PI3-kinase inhibitor GDC-0941 with paclitaxel (P) and carboplatin (C), with and without bevacizumab (BEV), in patients with advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 29(15_suppl). 3044–3044. 18 indexed citations
18.
Helfrich, Miep, Stephen A. Nesbitt, Päivi T. Lakkakorpi, et al.. (1996). β1 integrins and osteoclast function: Involvement in collagen recognition and bone resorption. Bone. 19(4). 317–328. 113 indexed citations
19.
Davison, Ian G., G. Shankar, M.A. Horton, & William T. Mason. (1994). Integrin‐dependent Mobilization of Intracellular Calcium Ions in Osteoclasts. Annals of the New York Academy of Sciences. 710(1). 287–300. 4 indexed citations
20.
Shankar, G. & Paula H. Stern. (1993). Evaluation of the role of second messenger systems in tumor necrosis factor-stimulated resorption of fetal rat limb bones. Bone. 14(6). 871–876. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Sotoudeh Breakdown of academic impact, for papers by Guanzhi Liu Breakdown of academic impact, for papers by Zhengxiang Yang Breakdown of academic impact, for papers by Guangwen Wang Breakdown of academic impact, for papers by Shaolong Zhou Breakdown of academic impact, for papers by Q Mai Breakdown of academic impact, for papers by Jae-Il Choi Breakdown of academic impact, for papers by Shiwang Li Breakdown of academic impact, for papers by Yan‐Bin Ma Breakdown of academic impact, for papers by Hongbo Lu
Rankless by CCL
2026